INTENSITY THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4 USD | +6.38% |
|
+3.63% | -53.33% |
Chart calendar Intensity Therapeutics, Inc.
1001410e948000f10091a9808.WLEUu8LYVs5S7h1ZQV7TFvhqoboQ5wBIrtjObmrAu0I.KsNhipq7EIgC20UgFRD-R8kH1PY9tUgy6erjBjux9y1h3VLRs7Izqx67fg~f23f08996ce8c861e644f2e990536b28
Upcoming events on Intensity Therapeutics, Inc.
Past events on Intensity Therapeutics, Inc.
| 2024-05-09 16:08 | Q1 2024 Earnings Release |
| 2024-04-09 15:30 | LD Micro Invitational Conference |
| 2024-03-19 15:30 | Roth Conference |
| 2024-03-14 16:09 | Q4 2023 Earnings Release |
| 2024-02-26 11:45 | BIO CEO & Investor Conference |
| 2023-12-08 08:00 | San Antonio Breast Cancer Symposium - PS16-03 |
| 2023-11-13 08:01 | Q3 2023 Earnings Release |
| 2023-10-31 | Connective Tissue Oncology Society Meeting - Abstract Number: 1574238 |
| 2023-10-04 15:30 | LD Micro Main Conference |
| 2023-09-11 16:30 | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 | Q2 2023 Earnings Call |
| 2023-08-14 07:01 | Q2 2023 Earnings Release |
| 2022-12-08 08:00 | San Antonio Breast Cancer Symposium - Poster Number : PD11-02 |
| 2022-11-18 18:30 | Connective Tissue Oncology Society Meeting - Abstract No: 1301741 |
| 2022-11-11 09:00 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 710 |
| 2022-11-10 09:00 | Society for Immunotherapy of Cancer Meeting - Abstract No: 545 |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -8,32 -7,52 -10.68% | -10,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -10,5 -11,1 5.07% | -9,35 |
|
Net income Million USD | Released Forecast Spread | -7,58 | -11,9 -11,1 -6.86% | -9,35 |
|
EPS USD | Released Forecast Spread | -2,22 | -1,38 -2,32 40.52% | -0,92 |
| Announcement Date | 18/05/23 | 14/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -1,22 -1,30 6.02% | -2,49 -1,50 -66.03% | -3,35 -2,55 -31.48% | ||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -3,70 -1,38 -167.96% | -2,33 -1,26 -84.9% | -3,17 -2,41 -31.59% | ||||
|
Net income Million USD | Released Forecast Spread | -3,70 -1,38 -167.96% | -2,33 -1,26 -84.9% | -4,50 -2,41 -86.52% | ||||
|
EPS USD | Released Forecast Spread | -1,05 -0,40 -162.5% | -0,17 -0,09 -88.89% | -0,12 -0,18 33.33% | -0,34 0,00 - | 0,00 | 0,00 | 0,00 |
| Announcement Date | 14/08/23 | 13/11/23 | 14/03/24 | 09/05/24 | - | - | - |
More events
Past sector events for Intensity Therapeutics, Inc.
| 2024-05-10 07:00 | HUMACYTE, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | NOVAVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 | TAKARA BIO INC.: Q4 2023 Earnings Release |
| 2024-05-09 | CHABIOTECH CO.,LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-05-09 16:10 | GYRE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | ARS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | HILLEVAX, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | BIOHAVEN LTD.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | OMNIAB, INC.: Q1 2024 Earnings Release |
| 2024-05-09 16:05 | 4D MOLECULAR THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INTS Stock
- Calendar Intensity Therapeutics, Inc.